Cargando…
Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy
Despite advances in its treatment, heart failure remains a major cause of morbidity and mortality, evidencing an urgent need for novel mechanism-based targets and strategies. Myocardial hypertrophy, caused by a wide variety of chronic stress stimuli, represents an independent risk factor for the dev...
Autores principales: | Aluja, David, Delgado-Tomás, Sara, Ruiz-Meana, Marisol, Barrabés, José A., Inserte, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032729/ https://www.ncbi.nlm.nih.gov/pubmed/35456920 http://dx.doi.org/10.3390/ijms23084103 |
Ejemplares similares
-
Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction
por: Inserte, Javier, et al.
Publicado: (2021) -
Targeted Inhibition of Calpain Reduces Myocardial Hypertrophy and Fibrosis in Mouse Models of Type 1 Diabetes
por: Li, Ying, et al.
Publicado: (2011) -
Connexin 43 Deficiency Is Associated with Reduced Myocardial Scar Size and Attenuated TGFβ1 Signaling after Transient Coronary Occlusion in Conditional Knock-Out Mice
por: Valls-Lacalle, Laura, et al.
Publicado: (2020) -
Cardiac metabolism as a driver and therapeutic target of myocardial infarction
por: Zuurbier, Coert J., et al.
Publicado: (2020) -
Citric Acid Cycle Metabolites Predict Infarct Size in Pigs Submitted to Transient Coronary Artery Occlusion and Treated with Succinate Dehydrogenase Inhibitors or Remote Ischemic Perconditioning
por: Consegal, Marta, et al.
Publicado: (2021)